Incyte (INCY) Long-Term Debt Repayments (2010 - 2016)
Incyte posted quarterly Long-Term Debt Repayments of $445000.0 for Q1 2016, down 1.55% year-on-year from $452000.0 in Q2 2015, and up 39.06% on a QoQ basis from $320000.0 in Q4 2015.
Incyte (INCY) has 4 years of Long-Term Debt Repayments data on file, last reported at $445000.0 in Q1 2016.
- For the quarter ending Q1 2016, Long-Term Debt Repayments fell 1.55% year-over-year to $445000.0; the trailing twelve-month figure through Dec 2016 stood at $445000.0 (down 73.81% YoY), and the FY2016 full-year result was $445000.0, down 73.81% from the prior year.
- Long-Term Debt Repayments for Q1 2016 stood at $445000.0, up from $320000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $488.7 million in Q4 2013 and bottomed at $320000.0 in Q4 2015.
- The 3-year median for Long-Term Debt Repayments is $463500.0 (2015), against an average of $64.0 million.
- Peak annual rise in Long-Term Debt Repayments reached 1.55% in 2016, while the deepest fall reached 1.55% in 2016.
- A 3-year view of Long-Term Debt Repayments shows it stood at $488.7 million in 2013, then sank by 99.93% to $320000.0 in 2015, then surged by 39.06% to $445000.0 in 2016.
- The last three Long-Term Debt Repayments figures came in at $445000.0 (Q1 2016), $320000.0 (Q4 2015), and $467000.0 (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 445,000.00 |
| Mar 31, 2016 | 445,000.00 |
| Dec 31, 2015 | 320,000.00 |
| Dec 31, 2015 | 320,000.00 |
| Sep 30, 2015 | 467,000.00 |
| Sep 30, 2015 | 467,000.00 |
| Jun 30, 2015 | 460,000.00 |
| Jun 30, 2015 | 460,000.00 |
| Mar 31, 2015 | 452,000.00 |
| Mar 31, 2015 | 452,000.00 |
| Dec 31, 2013 | 488.73 Mn |
| Dec 31, 2013 | 488.73 Mn |
| Sep 30, 2013 | 11.30 Mn |
| Sep 30, 2013 | 11.30 Mn |
| Jun 30, 2013 | 9.80 Mn |
| Jun 30, 2013 | 9.80 Mn |
| Mar 31, 2010 | 158.64 Mn |
| Mar 31, 2010 | 158.64 Mn |